Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Principia Biopharma Inc. | 2,038,208 | reported | 18 Sept 2018 | tx 9+2,038,208−1,768,208 |
| Aclaris Therapeutics, Inc. | 714,823 | reported | 06 Jun 2025 | tx 40+3,562,483−7,285,506 |
| ALIMERA SCIENCES INC | 506,270 | reported | 12 Sept 2014 | tx 4+2,546,290−2,166,667 |
| AERIE PHARMACEUTICALS INC | 469,591 | reported | 15 Apr 2015 | tx 22+3,415,789−15,767,835 |
| MARINUS PHARMACEUTICALS INC | 7,700 | reported | 03 Aug 2016 | tx 4+23,300 |
| aTYR PHARMA INC | 0 | reported | 12 May 2015 | tx 3+1,866,126−14,968,722 |
| Merus N.V. | 0 | reported | 12 Dec 2025 | tx 16+67,806−103,939 |
| Spark Therapeutics, Inc. | 0 | reported | 17 Dec 2019 | tx 67+2,206,001−4,106,558 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Dec 2025 | OTHER | Merus N.V. | 17,000 | 0.00 USD | deriv |
| 12 Dec 2025 | OTHER | Merus N.V. | 5,650 | 0.00 USD | deriv |
| 12 Dec 2025 | OTHER | Merus N.V. | 4,983 | 0.00 USD | deriv |
| 12 Dec 2025 | OTHER | Merus N.V. | 8,500 | 0.00 USD | deriv |
| 12 Dec 2025 | OTHER | Merus N.V. | 13,193 | 0.00 USD | deriv |
| 12 Dec 2025 | OTHER | Merus N.V. | 8,844 | 0.00 USD | deriv |
| 12 Dec 2025 | OTHER | Merus N.V. | 14,414 | 0.00 USD | deriv |
| 12 Dec 2025 | OTHER | Merus N.V. | 16,604 | 0.00 USD | deriv |
| 12 Dec 2025 | OTHER | Merus N.V. | 6,120 | 0.00 USD | deriv |
| 12 Dec 2025 | OTHER | Merus N.V. | 8,631 | 0.00 USD | deriv |
| 06 Jun 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 4,793 | — | |
| 06 Jun 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 4,793 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 42,350 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 11,580 | 0.00 USD | deriv |
| 22 May 2025 | GRANT_AWARD | Merus N.V. | 13,193 | 0.00 USD | deriv |
| 19 Nov 2024 | PURCHASE | Aclaris Therapeutics, Inc. | 666,666 | 2.25 USD | first after silence |
| 06 Jun 2024 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 15,750 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 4,793 | 0.00 USD | deriv |
| 01 Jun 2024 | EXERCISE | Aclaris Therapeutics, Inc. | 4,660 | — | |
| 01 Jun 2024 | EXERCISE | Aclaris Therapeutics, Inc. | 4,660 | 0.00 USD | deriv |
| 07 May 2024 | GRANT_AWARD | Merus N.V. | 8,844 | 0.00 USD | deriv |
| 08 Jun 2023 | GRANT_AWARD | Merus N.V. | 14,414 | 0.00 USD | deriv |
| 02 Jun 2023 | EXERCISE | Aclaris Therapeutics, Inc. | 4,507 | — | |
| 01 Jun 2023 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 15,750 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 4,660 | 0.00 USD | deriv |
3 purchases reported after at least 12 months of silence — most recent on 19 Nov 2024.